Gene therapy for stem cells may improve sickle cell disease treatment

07/3/2013 | Los Angeles Wave

Researchers at the University of California at Los Angeles are working on a gene therapy for bone marrow stem cells that could allow patients with sickle cell disease, who do not have a bone marrow match, to receive transplants using their own modified bone marrow. The treatment involves the addition of an anti-sickling gene in patients' hematopoietic stem cells. Researchers hope to initiate human trials in 2014. Their work is outlined in an online report in the Journal of Clinical Investigation.

View Full Article in:

Los Angeles Wave

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC